Skip to main content
. 2022 Jan 19;27:998–1009. doi: 10.1016/j.omtn.2022.01.010

Figure 1.

Figure 1

Schematic illustration of CP-bi-apt for enhancing antitumor immunotherapy

Adoptive NK cells can induce robust immune response with the engagement of CP-bi-apt. Moreover, CP-bi-apt also can enhance the antitumor effect through PD-L1 immune checkpoint blockade.